Viatris Inc (VTRS)
11.96
-0.04
(-0.33%)
USD |
NASDAQ |
Jan 08, 16:00
11.90
-0.06
(-0.50%)
After-Hours: 04:50
Viatris SG&A Expense (Quarterly): 1.003B for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Lexicon Pharmaceuticals Inc | 39.59M |
| Moderna Inc | 281.00M |
| Baxter International Inc | 754.00M |
| Boston Scientific Corp | 1.562B |
| Insulet Corp | 234.10M |